Evidence map›Paper›PMID 31062448›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2019

Preparation and Characterization of Dentin Phosphophoryn-Derived Peptide-Functionalized Lignin Nanoparticles for Enhanced Cellular Uptake.

Patrícia Figueiredo, Mika H Sipponen, Kalle Lintinen, Alexandra Correia, Alexandros Kiriazis, Jari Yli-Kauhaluoma, Monika Österberg, Anne George, Jouni Hirvonen, Mauri A Kostiainen and 1 more

Open access · greenAbstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Nanotechnology-Assisted Cell Tracking.Nanomaterials (Basel, Switzerland) · 2022
    Review
  8. Article
  9. Article
  10. Multifunctional lignin-based nanocomposites and nanohybrids.Green chemistry : an international journal and green chemistry resource : GC · 2021
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Patrícia FigueiredoDrug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland.
Mika H SipponenSchool of Chemical Engineering, Department of Bioproducts and Biosystems, Aalto University, FI-00076, Aalto, Finland.
Kalle LintinenBiohybrid Materials, Department of Bioproducts and Biosystems, Aalto University, FI-00076, Aalto, Finland.
Alexandra CorreiaDrug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland.
Alexandros KiriazisDrug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland.
Jari Yli-KauhaluomaDrug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland.
Monika ÖsterbergSchool of Chemical Engineering, Department of Bioproducts and Biosystems, Aalto University, FI-00076, Aalto, Finland.
Anne GeorgeBrodie Tooth Development Genetics and Regenerative Medicine Research Laboratory Department of Oral Biology, University of Illinois, Chicago, IL, 60612, USA.
Jouni HirvonenDrug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland.
Mauri A KostiainenBiohybrid Materials, Department of Bioproducts and Biosystems, Aalto University, FI-00076, Aalto, Finland.
Hélder A SantosDrug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland.ORCID 0000-0001-7850-6309
University of Helsinki · FIAalto University · FIUniversity of Illinois Urbana-Champaign · US

Funding

The Role of DPP in Dental Pulp Stem Cells and its Potential in Tissue RegenerationR01DE028531 · NIDCR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GEORGE, ANNE · 2019 to 2023
$1.9M
NIDCR NIH HHS R01 DE028531
6 · The paper itself

Abstract

The surface modification of nanoparticles (NPs) using different ligands is a common strategy to increase NP-cell interactions. Here, dentin phosphophoryn-derived peptide (DSS) lignin nanoparticles (LNPs) are prepared and characterized, the cellular internalization of the DSS-functionalized LNPs (LNPs-DSS) into three different cancer cell lines is evaluated, and their efficacy with the widely used iRGD peptide is compared. It is shown that controlled extent of carboxylation of lignin improves the stability at physiological conditions of LNPs formed upon solvent exchange. Functionalization with DSS and iRGD peptides maintains the spherical morphology and moderate polydispersity of LNPs. The LNPs exhibit good cytocompatibility when cultured with PC3-MM2, MDA-MB-231, and A549 in the conventional 2D model and in the 3D cell spheroid morphology. Importantly, the 3D cell models reveal augmented internalization of peptide-functionalized LNPs and improve antiproliferative effects when the LNPs are loaded with a cytotoxic compound. Overall, LNPs-DSS show equal or even superior cellular internalization than the LNPs-iRGD, suggesting that DSS can also be used to enhance the cellular uptake of NPs into different types of cells, and release different cargos intracellularly.

Indexed as

A549 CellsAntineoplastic AgentsBiological TransportCell ProliferationDentin SialophosphoproteinDrug CarriersDrug LiberationExtracellular Matrix ProteinsHumansLigninMaterials TestingNanoparticlesPC-3 CellsPeptidesPhosphoproteinsSialoglycoproteinsAntineoplastic AgentsDentin SialophosphoproteinDrug CarriersExtracellular Matrix ProteinsLigninPeptidesPhosphoproteinsSialoglycoproteins3D cell culturebenzazulenebiofunctionalizationdentin phosphophoryn peptidelignin nanoparticles

Identifiers

PMID31062448
PMCPMC8042775
OpenAlexW2944456323

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.